Oil prices hold sharp losses with focus on secondary India tariffs
Debra A. Cafaro, Chairman and CEO of Ventas, Inc. (NYSE:VTR), a prominent healthcare REIT with a market capitalization of $30.7 billion, sold 10,322 shares of common stock on August 1, 2025, for a total of $695,722. The sales were executed at a weighted average price of $67.4019, with individual sales prices ranging from $66.67 to $67.85, near the stock’s 52-week high of $71.36. According to InvestingPro analysis, VTR has delivered strong returns over the past five years.
On the same day, Cafaro also exercised options to acquire 10,322 shares of Ventas common stock at a price of $65.45 per share, for a total value of $675574.
Following these transactions, Cafaro directly owns 1,145,695 shares of Ventas, Inc. The reported transactions were executed pursuant to a Rule 10b5-1 trading plan.
In other recent news, Ventas Inc reported better-than-expected earnings for the second quarter of 2025. The company achieved an earnings per share (EPS) of $0.15, surpassing the forecast of $0.14. Additionally, Ventas Inc’s revenue reached $1.42 billion, exceeding the anticipated $1.37 billion. These results mark a significant development for the company, indicating strong growth in the latest quarter. Investors and analysts closely monitor such financial outcomes as they provide insights into the company’s performance. The earnings and revenue figures are crucial for stakeholders evaluating the company’s financial health. These recent developments reflect Ventas Inc’s ability to outperform market expectations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.